🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro savings card update — July 2024 Page 6

Mounjaro savings card update — July 2024

tammy_FL Wed, Feb 7, 2024 at 5:59 PM 60 replies 3,510 viewsPage 6 of 12
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Feb 10, 2024 at 4:19 PM#26
lisa_labSD said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

36 9jim_asheville, matt_MKE, Dr.ReproEndo and 33 others
Reply Quote Save Share Report
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Feb 10, 2024 at 10:43 PM#27
lisa_labSD said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Last edited: Feb 11, 2024 at 3:43 AM
37 10amsterdam_pete, LondonLisa, mike_nyc and 34 others
Reply Quote Save Share Report
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Feb 11, 2024 at 5:07 AM#28
lisa_labSD said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

This answered a question I did not know how to ask. I will report back once I have actually tried it.

38 11JennaRN, LabKate, kate.chem and 35 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Feb 11, 2024 at 11:31 AM#29

Clinical perspective, offered as context rather than as advice. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Last edited: Feb 11, 2024 at 5:31 PM
39 12mike.trainer_LA, sarah_nash92, FitDadDave and 36 others
Reply Quote Save Share Report
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Feb 11, 2024 at 5:55 PM#30

Closing the loop on my own question.

Coming back a few months on. It held. Nothing dramatic to report, which is the report.

11 9mike_mealprep, NicoleRaleigh, james_edin and 8 others
Reply Quote Save Share Report
14567812

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register